NYEGAARD & CO AS has a total of 390 patent applications. Its first patent ever was published in 1926. It filed its patents most often in United Kingdom, Denmark and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are RORER INT OVERSEAS, CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA and NEUROCHEM INTERNAT LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 38 | |
#2 | Denmark | 35 | |
#3 | United States | 30 | |
#4 | Germany | 25 | |
#5 | Norway | 24 | |
#6 | Switzerland | 22 | |
#7 | Finland | 22 | |
#8 | France | 21 | |
#9 | Japan | 21 | |
#10 | Spain | 17 | |
#11 | Sweden | 17 | |
#12 | EPO (European Patent Office) | 16 | |
#13 | Canada | 14 | |
#14 | Ireland | 12 | |
#15 | South Africa | 12 | |
#16 | Austria | 11 | |
#17 | Australia | 11 | |
#18 | Netherlands | 8 | |
#19 | Belgium | 7 | |
#20 | New Zealand | 6 | |
#21 | Italy | 5 | |
#22 | Brazil | 4 | |
#23 | Hong Kong | 3 | |
#24 | Israel | 2 | |
#25 | Philippines | 2 | |
#26 | Argentina | 1 | |
#27 | Mexico | 1 | |
#28 | Portugal | 1 | |
#29 | Singapore | 1 | |
#30 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Biotechnology | |
#5 | Computer technology | |
#6 | Civil engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Unspecified technologies | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Peptides | |
#7 | Sugars | |
#8 | Construction of roads | |
#9 | Measuring microorganism processes | |
#10 | Speech analysis |
# | Name | Total Patents |
---|---|---|
#1 | Undheim Kjell | 52 |
#2 | Benneche Tore | 27 |
#3 | Nordal V | 23 |
#4 | Holtermann Hugo | 21 |
#5 | Nordal Vegard | 18 |
#6 | Gacek Mikkel Josef | 18 |
#7 | Holtermann H | 16 |
#8 | Haavaldsen J | 15 |
#9 | Hugo Holtermann | 14 |
#10 | Undheim K | 14 |
Publication | Filing date | Title |
---|---|---|
GB8530564D0 | Chemical compounds | |
GB8530565D0 | Chemical compounds | |
EP0184899A1 | Paramagnetic contrast agents for use in "in vivo" diagnostic methods using NMR, and their preparation | |
EP0186947A1 | Paramagnetic contrast agents for use in "in vivo" diagnostic methods using NMR, and their preparation | |
GB8525974D0 | Chemical substance | |
SE8405500D0 | Diagnostic particles containing a paramagnetic metal | |
SE8405501D0 | Particulate diagnostic agent containing a paramagnetic metal | |
GB8413772D0 | Chemical compounds | |
GB8411291D0 | Chemical compounds | |
GB8408127D0 | Contrast agents | |
GB8400530D0 | Substituted pyrimidines and processes for their preparation | |
ZA8308780B | Peptide compounds | |
EP0108638A1 | X-ray contrast agents | |
CA1200495A | Pyrimidine-2-sulphides and their s-oxides for use in medicine and methods of use therefor, pharmaceutical compositions containing them, processes for their preparation and suchcompounds when novel per se | |
GB8327966D0 | Chemical compounds | |
DK451983D0 | Three-benzen derivatives, procedures for preparing thereof and radiological preparations containing such relationships | |
GB8319672D0 | Chemical compound | |
IE830395L | Pyrimidines | |
EP0087326A1 | Substituted pyrimidin-2-ones and the salts thereof | |
GB8300585D0 | Substituted pyrimidines |